$CRSP 8-K SEC Filings

Filed On	Filing
19 Oct 2026	8-K: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers This Employment Agreement (“Agreement”) is made as of the Nineteenth (19th) day of October, 2026 between CRISPR Therapeutics, Inc., a Delaware corporation (the “Company”), and Andrew J. Silver (the “Executive” and, together with the Comp...
03 Aug 2026	8-K: Results of Operations and Financial Condition
04 Jun 2026	8-K: Departure/Election of Directors or Officers; Compensation; Amendments to Articles/Bylaws; Change in Fiscal Year +1 more
04 May 2026	8-K: Results of Operations and Financial Condition
16 Mar 2026	8-K: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation +1 more
11 Mar 2026	8-K: Other Events
12 Feb 2026	8-K: Results of Operations and Financial Condition
12 Jan 2026	8-K: Other Events
10 Nov 2025	8-K: Results of Operations and Financial Condition
15 Oct 2025	8-K: Other Events
04 Aug 2025	8-K: Results of Operations and Financial Condition
26 Jun 2025	8-K: Other Events
09 Jun 2025	8-K: Amendments to Articles/Bylaws; Change in Fiscal Year; Submission of Matters to a Vote of Security Holders
19 May 2025	8-K: Entry into a Material Definitive Agreement; Other Events
06 May 2025	8-K: Results of Operations and Financial Condition
26 Mar 2025	8-K: Departure/Election of Directors or Officers; Compensation
11 Feb 2025	8-K: Results of Operations and Financial Condition
05 Nov 2024	8-K: Results of Operations and Financial Condition
05 Aug 2024	8-K: Results of Operations and Financial Condition
03 Jun 2024	8-K: Departure/Election of Directors or Officers; Compensation; Amendments to Articles/Bylaws; Change in Fiscal Year +1 more

Comments